Updated:
Sightpath Medical
Sightpath Medical is the leading U.S. mobile ophthalmic services provider for cataract and refractive surgery, serving 1,300+ surgeons across 850...
Sightpath Medical
Sightpath Medical is the leading U.S. provider of mobile ophthalmic services for cataract and refractive surgery, according to the firm's website. The company has no publicly disclosed founding year or named principals on its website. The firm offers mobile phacoemulsification machines, excimer lasers, the IntraLase Femtosecond Laser, and the LenSx Femtosecond Laser. It claims to be the only manufacturer-approved provider of the mobile LenSx femtosecond laser. Equipment and supplies, plus service and expertise, are the complete solution offered to surgeons and facilities. Sightpath employees travel over 3 million miles annually to deliver services. More than 190 Sightpath employees serve hundreds of surgeons and facilities in both rural and urban communities across the country. Over 1,300 surgeons and over 750 hospitals and ASCs are supported. Approximately 3,000,000 patient eyes have been improved. April 2025: Sightpath Medical and Custom Surgical Partners collaborate to support office-based cataract surgery (per the firm, April 2025). Sightpath Medical's structural differentiator is its position as the leading mobile equipment and services provider in a niche market, rather than operating as a traditional family office or asset manager. This is not a typical investment firm but an operating company providing outsourced ophthalmic surgery services.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bloomington
Corporate office
Bloomington, MN, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Sightpath Medical?
Sightpath Medical does not publicly disclose its principals or investment decision-makers on its website. The firm presents itself as an operating company providing mobile ophthalmic services, not as a traditional investment manager.
How does Sightpath Medical source proprietary deal flow?
Sightpath Medical does not publicly describe a proprietary deal flow process. Its business model involves contracting with surgeons and facilities to provide mobile ophthalmic equipment and services, which is operational rather than investment-driven.
Is Sightpath Medical structured as a single family office or does it operate more like a venture firm?
Based on public information, Sightpath Medical appears to be an operating company, not a family office or venture firm. It provides mobile ophthalmic services and does not disclose investment activities or a family office structure.
Does Sightpath Medical participate in fund commitments or only direct deals?
Sightpath Medical does not publicly disclose any fund commitments or direct investment deals. The firm's known activities are limited to providing mobile ophthalmic surgical equipment and services.
What investment stages does Sightpath Medical typically target?
Sightpath Medical does not target investment stages. The firm is an operating company that provides mobile ophthalmic equipment and services to surgeons and facilities, not an investment firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: